Circulating Vitamin D Levels in Patients With Systemic Sclerosis: a Meta-Analysis

 

 Buy Article Permissions and Reprints

Abstract

Objective This study aimed to evaluate the relationship between circulating vitamin D levels and systemic sclerosis and to establish an association between vitamin D deficiency and systemic sclerosis.

Methods We performed a meta-analysis comparing the plasma/serum vitamin D levels and vitamin D deficiency between patients with systemic sclerosis and healthy controls and examined correlation coefficients between circulating vitamin D levels and the Rodnan score.

Results Twenty-one studies involving 1,399 patients with systemic sclerosis and 1,311 controls were included. The systemic sclerosis group had significantly lower vitamin D levels than the control group. Stratification by ethnicity demonstrated significantly decreased vitamin D levels in patients with systemic sclerosis among European, Asian, Arab, Latin American, and mixed populations. Stratification by age, sex, and/or body mass index revealed significantly lower vitamin D levels in the systemic sclerosis group regardless of the adjustment. Subgroup analysis by sample size revealed significantly lower vitamin D levels in the systemic sclerosis group by small (n<100) and large sample numbers (n>100). Stratification by publication year revealed significantly lower vitamin D levels in the systemic sclerosis group in both recent and old publication years. However, no significant difference in vitamin D levels was observed between diffuse and limited types of systemic sclerosis. Vitamin D deficiency was significantly associated with systemic sclerosis. The meta-analysis of correlation coefficients revealed a tendency of inverse correlation between circulating vitamin D levels and the Rodnan score.

Conclusions Patients with systemic sclerosis had lower circulating vitamin D levels and higher vitamin D deficiency and there was a tendency of inverse correlation between circulating vitamin D levels and the Rodnan score.

Publication History

Article published online:
20 September 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Lee S-G, Moon KW. Epidemiology and Treatment of Systemic Sclerosis in Korea. J Rheum Dis 2022; 29: 200-214 DOI: 10.4078/jrd.22.0029.
  CrossrefPubMedGoogle Scholar
• 2 An L, Sun MH, Chen F. et al. Vitamin D levels in systemic sclerosis patients: A meta-analysis. Drug Design, Development and Therapy 2017; 11: 3119
  CrossrefPubMedGoogle Scholar
• 3 Pattanaik D, Brown M, Postlethwaite BC. et al. Pathogenesis of systemic sclerosis. Frontiers in immunology 2015; 6: 272
  CrossrefPubMedGoogle Scholar
• 4 Cantorna MT. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence?. Proc Soc Exp Biol Med 2000; 223: 230-233
  CrossrefPubMedGoogle Scholar
• 5 Maruotti N, Cantatore FP. Vitamin D and the immune system. J Rheumatol 2010; 37: 491-495 DOI: 10.3899/jrheum.090797.
  CrossrefPubMedGoogle Scholar
• 6 Kamen D, Aranow C. Vitamin D in systemic lupus erythematosus. Curr Opin Rheumatol 2008; 20: 532-537 DOI: 10.1097/BOR.0b013e32830a991b00002281-200809000-00004. [pii]
  CrossrefPubMedGoogle Scholar
• 7 Cutolo M, Otsa K, Paolino S. et al. Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus. Ann Rheum Dis 2009; 68: 446-447 DOI: 10.1136/ard.2008.093476.
  CrossrefPubMedGoogle Scholar
• 8 Wen H, Baker JF. Vitamin D, immunoregulation, and rheumatoid arthritis. J Clin Rheumatol 2011; 17: 102-107 DOI: 10.1097/RHU.0b013e31820edd1800124743-201103000-00014. [pii]
  CrossrefPubMedGoogle Scholar
• 9 Lee YH, Bae S-C. Vitamin D level in rheumatoid arthritis and its correlation with the disease activity: a meta-analysis. Clin Exp Rheumatol 2016; 34: 827-833
  PubMedGoogle Scholar
• 10 Song G, Bae S, Lee Y. Vitamin D receptor FokI, BsmI, and TaqI polymorphisms and susceptibility to rheumatoid arthritis: A meta-analysis. Zeitschrift fur Rheumatologie 2016; 75: 322-329
  CrossrefPubMedGoogle Scholar
• 11 Bae S-C, Lee YH. Vitamin D receptor FokI, TaqI, and ApaI polymorphisms and susceptibility to systemic lupus erythematosus: an updated meta-analysis. Clinical Rheumatology 2018; 37: 1529-1537
  CrossrefPubMedGoogle Scholar
• 12 Diaconu A-D, Ostafie I, Ceasovschih A. et al. Role of Vitamin D in Systemic Sclerosis: A Systematic Literature Review. Journal of Immunology Research 2021; 2021
  PubMedGoogle Scholar
• 13 El Gharbawy NH, Sheha DS, Bawady SA. et al. Vascular endothelial growth factor profile and Vitamin D level in Systemic Sclerosis Egyptian patients. The Egyptian Journal of Immunology 2021; 28: 168-175
  CrossrefPubMedGoogle Scholar
• 14 Isola G, Palazzo G, Polizzi A. et al. Association of systemic sclerosis and periodontitis with vitamin D levels. Nutrients 2021; 13: 705
  CrossrefPubMedGoogle Scholar
• 15 Hax V, Gasparin AA, Schneider L. et al. Vitamin D and cytokine profiles in patients with systemic sclerosis. JCR: Journal of Clinical Rheumatology 2020; 26: 289-294
  PubMedGoogle Scholar
• 16 Taylan A, Birlik M, Kenar G. et al. Osteoprotegrin interacts with biomarkers and cytokines that have roles in osteoporosis, skin fibrosis, and vasculopathy in systemic sclerosis: a potential multifaceted relationship between OPG/RANKL/TRAIL and Wnt inhibitors. Modern Rheumatology 2019; 29: 619-624
  CrossrefPubMedGoogle Scholar
• 17 Horváth Á, Végh E, Pusztai A. et al. Complex assessment of bone mineral density, fracture risk, vitamin D status, and bone metabolism in Hungarian systemic sclerosis patients. Arthritis Research & Therapy 2019; 21: 1-10
  CrossrefPubMedGoogle Scholar
• 18 Kotyla PJ, Kruszec-Zytniewska A, Owczarek AJ. et al. Fibroblast growth factor 23 to alpha-klotho index correlates with systemic sclerosis activity: a proposal for novel disease activity marker. Journal of Clinical Medicine 2018; 7: 558
  CrossrefPubMedGoogle Scholar
• 19 Gupta S, Mahajan VK, Yadav RS. et al. Evaluation of serum vitamin D levels in patients with systemic sclerosis and healthy controls: results of a pilot study. Indian Dermatology Online. Journal 2018; 9: 250
  PubMedGoogle Scholar
• 20 Hajialilo M, Noorabadi P, Tahsini Tekantapeh S. et al. Endothelin-1, α-Klotho, 25 (OH) Vit D levels and severity of disease in scleroderma patients. Rheumatology International 2017; 37: 1651-1657
  CrossrefPubMedGoogle Scholar
• 21 Ahmadi R, Hajialilo M, Ghorbanihaghjo A. et al. FGF-23, Klotho and vitamin D levels in scleroderma. Iranian journal of public health 2017; 46: 530
  PubMedGoogle Scholar
• 22 Park E-K, Park J-H, Kweon S-M. et al. Vitamin D deficiency is associated with digital ulcer but not with atherosclerosis or arterial stiffness in patients with systemic sclerosis: a pilot study. Clinical Rheumatology 2017; 36: 1325-1333
  CrossrefPubMedGoogle Scholar
• 23 Zhang L, Duan Y, Zhang TP. et al. Association between the serum level of vitamin D and systemic sclerosis in a Chinese population: a case control study. International Journal of Rheumatic Diseases 2017; 20: 1002-1008
  CrossrefPubMedGoogle Scholar
• 24 Atteritano M, Santoro D, Corallo G. et al. Skin involvement and pulmonary hypertension are associated with vitamin D insufficiency in scleroderma. International Journal of Molecular Sciences 2016; 17: 2103
  CrossrefPubMedGoogle Scholar
• 25 Corrado A, Colia R, Mele A. et al. Relationship between body mass composition, bone mineral density, skin fibrosis and 25 (OH) vitamin D serum levels in systemic sclerosis. PLoS One 2015; 10: e0137912
  CrossrefPubMedGoogle Scholar
• 26 Atteritano M, Sorbara S, Bagnato G. et al. Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: a case control study. PloS one 2013; 8: e66991
  CrossrefPubMedGoogle Scholar
• 27 Ibn Yacoub Y, Amine B, Laatiris A. et al. Bone density in Moroccan women with systemic scleroderma and its relationships with disease-related parameters and vitamin D status. Rheumatology international 2012; 32: 3143-3148
  CrossrefPubMedGoogle Scholar
• 28 Shinjo SK, Bonfá E, de Falco Caparbo V. et al. Low bone mass in juvenile onset sclerosis systemic: the possible role for 25-hydroxyvitamin D insufficiency. Rheumatology international 2011; 31: 1075-1080
  CrossrefPubMedGoogle Scholar
• 29 Seriolo B, Molfetta L, Cutolo M. Seasonal variations in serum levels of 25-hydroxyvitamin D in patients with systemic sclerosis. Clinical Rheumatology 2011; 30: 445-446
  CrossrefPubMedGoogle Scholar
• 30 Arnson Y, Amital H, Agmon-Levin N. et al. Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. Autoimmunity reviews 2011; 10: 490-494
  CrossrefPubMedGoogle Scholar
• 31 Belloli L, Ughi N, Marasini B. Vitamin D in systemic sclerosis. Clinical rheumatology 2011; 30: 145
  CrossrefPubMedGoogle Scholar
• 32 Orbach H, Zandman-Goddard G, Amital H. et al. Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Annals of the New York Academy of Sciences 2007; 1109: 385-400
  CrossrefPubMedGoogle Scholar
• 33 Matsuoka L, Dannenberg M, Wortsman J. et al. Cutaneous vitamin D3 formation in progressive systemic sclerosis. The Journal of Rheumatology 1991; 18: 1196-1198
  PubMedGoogle Scholar
• 34 Song G, Bae SC, Lee YH. Diagnostic accuracy of lung ultrasound for interstitial lung disease in patients with connective tissue diseases: a meta-analysis. Clin Exp Rheumatol 2016; 34: 11-16
  PubMedGoogle Scholar
• 35 Lee YH, Bae S-C. Association between interferon-γ+874 T/A polymorphism and susceptibility to autoimmune diseases: a meta-analysis. Lupus 2016; 25: 710-718
  CrossrefPubMedGoogle Scholar
• 36 Song GG, Kim J-H, Seo YH. et al. Meta-analysis of differentially expressed genes in primary Sjogren’s syndrome by using microarray. Human immunology 2014; 75: 98-104
  CrossrefPubMedGoogle Scholar
• 37 Moher D, Liberati A, Tetzlaff J. et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine 2009; 6: e1000097 DOI: 10.1371/journal.pmed.1000097.
  CrossrefPubMedGoogle Scholar
• 38 Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC medical research methodology 2005; 5: 13
  CrossrefPubMedGoogle Scholar
• 39 Ridout KK, Ridout SJ, Price LH. et al. Depression and telomere length: A meta-analysis. Journal of affective disorders 2016; 191: 237-247
  CrossrefPubMedGoogle Scholar
• 40 Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd edn. Hillsdale, New Jersey: L. In: Erlbaum. 1988
  Google Scholar
• 41 Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures. Bmj 1997; 315: 1533-1537
  CrossrefPubMedGoogle Scholar
• 42 DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188
  CrossrefPubMedGoogle Scholar
• 43 Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558 DOI: 10.1002/sim.1186.
  CrossrefPubMedGoogle Scholar
• 44 Egger M, Davey Smith G, Schneider M. et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634
  CrossrefPubMedGoogle Scholar
• 45 Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455-463
  CrossrefPubMedGoogle Scholar
• 46 Wacker M, Holick MF. Sunlight and Vitamin D: A global perspective for health. Dermato-endocrinology 2013; 5: 51-108
  CrossrefPubMedGoogle Scholar
• 47 Perazzi M, Gallina E, Manfredi GF. et al. Vitamin D in Systemic Sclerosis: A Review. Nutrients 2022; 14: 3908
  CrossrefPubMedGoogle Scholar
• 48 Umar M, Sastry KS, Chouchane AI. Role of vitamin D beyond the skeletal function: a review of the molecular and clinical studies. International journal of molecular sciences 2018; 19: 1618
  CrossrefPubMedGoogle Scholar
• 49 Di Rosa M, Malaguarnera M, Nicoletti F. et al. Vitamin D3: a helpful immuno-modulator. Immunology 2011; 134: 123-139
  CrossrefPubMedGoogle Scholar
• 50 Mızrak S, Kırnap M, Cüce İ. Neuropathic Pain and its Relationship With Fibromyalgia, Vitamin D Status and Medication Use in Patients With Ankylosing Spondylitis. J Rheum Dis 2021; 28: 126-132
  CrossrefPubMedGoogle Scholar